Primary care patient and clinician attitudes about population genomic screening, informed decision-making needs, and the potential for Chatbot technology

IF 1.9 4区 医学 Q3 GENETICS & HEREDITY
Rebecca R. Moultrie, Sara M. Andrews, Kristi M. Williams, Oksana Kutsa, Tarneisha Hudnell, Jennifer Brailsford, Sienna Aguilar, Sarah Savage, Barbara B. Biesecker, Jessica Ezzell Hunter
{"title":"Primary care patient and clinician attitudes about population genomic screening, informed decision-making needs, and the potential for Chatbot technology","authors":"Rebecca R. Moultrie,&nbsp;Sara M. Andrews,&nbsp;Kristi M. Williams,&nbsp;Oksana Kutsa,&nbsp;Tarneisha Hudnell,&nbsp;Jennifer Brailsford,&nbsp;Sienna Aguilar,&nbsp;Sarah Savage,&nbsp;Barbara B. Biesecker,&nbsp;Jessica Ezzell Hunter","doi":"10.1002/jgc4.70081","DOIUrl":null,"url":null,"abstract":"<p>The three CDC Tier 1 conditions (Hereditary Breast and Ovarian Cancer, Lynch Syndrome, and Familial Hypercholesterolemia) are estimated to affect 2 million people in the United States. Population-based genomic screening holds promise in identifying individuals who may not know their risk. This novel study explored primary care clinician and patient attitudes toward population screening generally and in the context of a research study and the potential for chatbot technology to support informed decision-making in the primary care context, perspectives vital to inform scalable, patient-centered approaches to facilitate population screening. We conducted semistructured interviews with primary care patients (<i>N</i> = 20) and primary care clinicians (<i>N</i> = 9) from primary care clinics at a patient-diverse academic medical center. The interviews focused on receptivity to population-level screening, information needs, and the potential for chatbot technology as a mechanism to support patient informed decision-aking about testing. Patient and clinician participants also reviewed a brief demonstration of the chatbot technology and shared their views. Interviews were recorded and transcribed. We used rapid qualitative analysis methodology to analyze interview data. Patients and clinicians acknowledged the benefits of population genomic screening and found the chatbot technology to be easy to navigate. Patients endorsed the utility of screening but raised concerns about data privacy and the desire for more information about the conditions and screening process. Clinicians gave insights into information that could be integrated to further support patients in informed decision-making. Overall, chatbot technology as a facilitator of population screening is a promising approach. The results of this study can improve future efforts to ensure that chatbots and similar technology incorporate vital information to facilitate informed decisions.</p>","PeriodicalId":54829,"journal":{"name":"Journal of Genetic Counseling","volume":"34 4","pages":""},"PeriodicalIF":1.9000,"publicationDate":"2025-07-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/jgc4.70081","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Genetic Counseling","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/jgc4.70081","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"GENETICS & HEREDITY","Score":null,"Total":0}
引用次数: 0

Abstract

The three CDC Tier 1 conditions (Hereditary Breast and Ovarian Cancer, Lynch Syndrome, and Familial Hypercholesterolemia) are estimated to affect 2 million people in the United States. Population-based genomic screening holds promise in identifying individuals who may not know their risk. This novel study explored primary care clinician and patient attitudes toward population screening generally and in the context of a research study and the potential for chatbot technology to support informed decision-making in the primary care context, perspectives vital to inform scalable, patient-centered approaches to facilitate population screening. We conducted semistructured interviews with primary care patients (N = 20) and primary care clinicians (N = 9) from primary care clinics at a patient-diverse academic medical center. The interviews focused on receptivity to population-level screening, information needs, and the potential for chatbot technology as a mechanism to support patient informed decision-aking about testing. Patient and clinician participants also reviewed a brief demonstration of the chatbot technology and shared their views. Interviews were recorded and transcribed. We used rapid qualitative analysis methodology to analyze interview data. Patients and clinicians acknowledged the benefits of population genomic screening and found the chatbot technology to be easy to navigate. Patients endorsed the utility of screening but raised concerns about data privacy and the desire for more information about the conditions and screening process. Clinicians gave insights into information that could be integrated to further support patients in informed decision-making. Overall, chatbot technology as a facilitator of population screening is a promising approach. The results of this study can improve future efforts to ensure that chatbots and similar technology incorporate vital information to facilitate informed decisions.

Abstract Image

初级保健患者和临床医生对人口基因组筛查、知情决策需求和聊天机器人技术潜力的态度
据估计,美国有200万人患有三种CDC一级疾病(遗传性乳腺癌和卵巢癌、Lynch综合征和家族性高胆固醇血症)。以人群为基础的基因组筛查有望识别出那些可能不知道自己风险的个体。这项新颖的研究探讨了初级保健临床医生和患者对人口筛查的态度,并在一项研究的背景下,探讨了聊天机器人技术在初级保健背景下支持知情决策的潜力,这些观点对于告知可扩展的、以患者为中心的方法来促进人口筛查至关重要。我们对来自不同患者类型学术医疗中心初级保健诊所的初级保健患者(N = 20)和初级保健临床医生(N = 9)进行了半结构化访谈。访谈的重点是对人群水平筛查的接受程度、信息需求以及聊天机器人技术作为一种支持患者知情决策的机制的潜力。与会的患者和临床医生还回顾了聊天机器人技术的简短演示,并分享了他们的观点。采访被记录下来并记录下来。我们使用快速定性分析方法来分析访谈数据。患者和临床医生承认人口基因组筛查的好处,并发现聊天机器人技术易于操作。患者赞同筛查的效用,但提出了对数据隐私的担忧,并希望获得有关条件和筛查过程的更多信息。临床医生提供了可以整合的信息,以进一步支持患者做出明智的决策。总的来说,聊天机器人技术作为人口筛查的推动者是一种很有前途的方法。这项研究的结果可以改善未来的努力,以确保聊天机器人和类似的技术纳入重要信息,以促进明智的决策。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of Genetic Counseling
Journal of Genetic Counseling GENETICS & HEREDITY-
CiteScore
3.80
自引率
26.30%
发文量
113
审稿时长
6 months
期刊介绍: The Journal of Genetic Counseling (JOGC), published for the National Society of Genetic Counselors, is a timely, international forum addressing all aspects of the discipline and practice of genetic counseling. The journal focuses on the critical questions and problems that arise at the interface between rapidly advancing technological developments and the concerns of individuals and communities at genetic risk. The publication provides genetic counselors, other clinicians and health educators, laboratory geneticists, bioethicists, legal scholars, social scientists, and other researchers with a premier resource on genetic counseling topics in national, international, and cross-national contexts.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信